All In Biotech

Free tool

FAERS Monitor: Diacomit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 206709 or its brand name (Diacomit, Stiripentol). Reports on generic versions are filed under their own applications.

Reports

2,283

Serious

1,959

86% of reports

Hospitalization

765

Death reported

121

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure928
  • off label use443
  • product use in unapproved indication351
  • drug ineffective306
  • decreased appetite265
  • somnolence246
  • product preparation issue201
  • product dose omission issue186
  • fatigue138
  • pyrexia113
  • weight decreased111
  • hospitalisation107
  • generalised tonic-clonic seizure90
  • diarrhoea84
  • pneumonia84

Reports by year received

View as table
YearReports
20044
20051
20063
20074
20085
20091
20103
201112
20125
20137
20145
201521
201614
201742
201850
2019239
2020247
2021284
2022276
2023186
2024234
2025303
2026337

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,876 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product preparation issueSignal201291.2254.656,086
seizureSignal92874.671.067,148
generalised tonic-clonic seizureSignal9050.441.14,286
product use in unapproved indicationSignal35113.111.93,939
somnolenceSignal24611.310.02,311
decreased appetiteSignal26510.59.42,297
hospitalisationSignal1076.45.3487
product dose omission issueSignal1865.85.1750
off label useSignal4434.74.31,326
weight decreasedSignal1113.73.1215
pyrexiaSignal1133.02.5152
pneumoniaSignal842.41.968
drug ineffectiveSignal3062.11.9197
fatigue1381.61.435
diarrhoea841.21.03

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.